IMB spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.

The National Health and Medical Research Council has named two UQ projects among its 10 of the Best Research Projects 2015, including IMB Group Leader Professor David Craik's project named “The scorpion king: lighting the way to defeating brain cancer”. These projects have led to ground-breaking medical discoveries and important changes to healthcare.

Applications are now open for the IMB Research Advancement Award, offering brilliant prospective PhD students the opportunity to secure a $30,000 top-up scholarship to support their studies at IMB.

IMB has welcomed three new research groups to bolster its investigations into neurological and psychiatric disorders, including motor neuron disease, Parkinson’s disease, dementia, autism and schizophrenia.

It is possible to combine family and a love of science. PhD graduate Rubbiya Ali looks back on everything she’s achieved at UQ, including mapping microalgae to help produce more efficient biofuels and having a son.

UQ Bachelor of Biomedical Science (honours) graduating student Samantha Nixon has been investigating compounds from tarantula venom as a potential treatment for sheep parasites which lead to huge economic losses for farmers.

Catch up on the free community seminar, Pain: Making it personal, hosted by the IMB Centre for Pain Research.

UQ IMB researcher Dr Joseph Powell has won the prestigious Commonwealth Minister’s Medal for Excellence in Health and Medical Research and the top-ranked RD Wright Career Development Fellowship.

The quality of research performed at The University of Queensland was recognised at last night’s (13 July) National Health and Medical Research Council (NHMRC) Research Excellence Awards in Canberra.